| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-321* | Cisplatin | ovarian cancer | Resistant | High | 19074899 | |
| miR-320a | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-320d | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-320e | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-32 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-320 | Cisplatin | lung adenocarcinoma | Sensitive | High | 23700794 | |
| miR-328 | Cisplatin | colorectal cancer | Sensitive | Low | 24318997 | |
| miR-320a | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 25356050 | |
| miR-320b | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 25356050 | |
| miR-320c | Cisplatin | esophageal squamous cell carcinoma | Sensitive | High | 25356050 | |
| miR-326 | Cisplatin | hepatocellular carcinoma | Sensitive | Low | 26239225 | |
| miR-320a | Cisplatin | small cell lung cancer | Resistant | High | 26676926 | |
| miR-320b | Cisplatin | small cell lung cancer | Resistant | High | 26676926 |